The following are funding resources for research on military psychological health.
Federally Funded Research Development Centers
Federally Funded Research Development Centers (FFRDCs) are independent entities that assist the federal government with scientific research, analysis, and development. FFRDCs assess critical, long-term problems of considerable complexity, provide immediate, short-term assistance for urgent high-priority issues, analyze technical questions with a high degree of objectivity, and provide creative and cost-effective solutions to government problems. Working in the public interest, FFRDCs operate as long-term strategic partners with their sponsoring agencies.
The Department of Defense sets aside funds so that the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (DCoE) may partner with FFRDCs. Such partnerships enable DCoE to use independent entities to produce research deliverables that are integral to the mission and operation of DCoE. FFRDC research with DCoE includes topics such as military psychological health, traumatic brain injury (TBI), stigma, sleep, family resilience, integrative medicine and cost-effectiveness/evaluation studies.
FFRDC Study Spotlight
The DHCC Research Directorate engages in psychological health knowledge translation and integration activities to promote the highest standards of care for services members and their families. The objectives of this initiative are to monitor ongoing research trials and identify gaps in evidence; sponsor systematic reviews that provide unbiased, meaningful, and actionable information on evidence-based practices; and expedite the translation of research findings into clinical practice guidelines and standard care.
Supporting CPG Development through Evidence Synthesis of Key CAM Topic Areas
As part of this effort, DCoE commissioned RAND Corporation to conduct 10 systematic reviews. These systematic reviews evaluate efficacy and comparative effectiveness of acupuncture, meditation, omega-3 fatty acids, and St. John’s Wort for psychological health conditions and comorbidities such as PTSD, major depressive disorder, substance use disorder, nicotine dependence, and chronic pain. Findings are used to inform the VA/DoD clinical practice guidelines (e.g., depression and substance use disorder guidelines) regarding up-to-date research findings in CAM applications for mental health.
Pathways, Experiences, and Outcomes of Primary Care Versus Specialty Care Treatment for PTSD and Depression in Active-duty Service Members
The purpose of this RAND study is to qualitatively examine how service members use mental health services (e.g., adherence and engagement), the underlying thought processes related to treatment decision-making, the experiences which shape their attitudes and perceptions, and how these factors influence care trajectories and outcomes. The findings from this study are expected to shed light on previous reports indicating that many service members with identified mental health needs do not complete an adequate course of treatment and to provide recommendations for process and policy improvements. This study is in its first year of funding with a projected end date in 2017.
The CDMRP originated in 1992 via a Congressional appropriation to foster novel approaches to biomedical research in response to the expressed needs of its stakeholders-the American public, the military, and Congress.
The NIMH OER serves as an interface between the NIH and the biomedical research community by guiding investigators through the process of attaining grants funding and helping them understand and navigate through federal policies and procedures.
AHRQ’s mission is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used.
PCORI is an independent nonprofit, nongovernmental organization located in Washington, DC, was authorized by Congress in 2010 who funds comparative clinical effectiveness research, or CER, as well as support work that will improve the methods used to conduct such studies.